A population based national study assessing the biosimilar use in patients with for inflammatory bowel disease [IBD] patients in United States between 2014-2019
Latest Information Update: 10 Jul 2020
At a glance
- Drugs Adalimumab (Primary) ; Infliximab (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Therapeutic Use
- 10 Jul 2020 New trial record